Literature DB >> 15006702

Characterization of the various forms of the Reelin protein in the cerebrospinal fluid of normal subjects and in neurological diseases.

Nina Ignatova1, Christian J M Sindic, André M Goffinet.   

Abstract

Reelin is a large extracellular glycoprotein that is defective in reeler mutant mice and plays a well-established role during brain development in human as well as rodents. In the adult brain, Reelin is expressed in a subset of GABAergic interneurons. Its role in disease states is not clearly defined, although it is implicated in autism and psychoses such as schizophrenia. In this report, we show that Reelin immunoreactive proteins can be detected in the human cerebrospinal fluid (CSF) with monoclonal antibodies directed against the N- and C-terminal regions of the protein. In CSF, Reelin is present as different products due to processing at two main sites; preservation at -20 degrees C increases processing further. CSF Reelin originates from the brain tissue and not from plasma. The protein was detected in comparable concentrations in children and adults, and the signal varied largely from subject to subject with no obvious correlation with age or neurological disease state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006702     DOI: 10.1016/j.nbd.2003.11.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  17 in total

1.  Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density.

Authors:  Justin T Rogers; Ian Rusiana; Justin Trotter; Lisa Zhao; Erika Donaldson; Daniel T S Pak; Lenard W Babus; Melinda Peters; Jessica L Banko; Pascale Chavis; G William Rebeck; Hyang-Sook Hoe; Edwin J Weeber
Journal:  Learn Mem       Date:  2011-08-18       Impact factor: 2.460

Review 2.  How does Reelin signaling regulate the neuronal cytoskeleton during migration?

Authors:  Xuejun Chai; Michael Frotscher
Journal:  Neurogenesis (Austin)       Date:  2016-09-29

3.  Reelin expression and glycosylation patterns are altered in Alzheimer's disease.

Authors:  Arancha Botella-López; Ferran Burgaya; Rosalina Gavín; M Salud García-Ayllón; Estrella Gómez-Tortosa; Jordi Peña-Casanova; Jesús M Ureña; José A Del Río; Rafael Blesa; Eduardo Soriano; Javier Sáez-Valero
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  C-Terminal Region Truncation of RELN Disrupts an Interaction with VLDLR, Causing Abnormal Development of the Cerebral Cortex and Hippocampus.

Authors:  Seungshin Ha; Prem P Tripathi; Anca B Mihalas; Robert F Hevner; David R Beier
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

Review 5.  The involvement of Reelin in neurodevelopmental disorders.

Authors:  Timothy D Folsom; S Hossein Fatemi
Journal:  Neuropharmacology       Date:  2012-09-07       Impact factor: 5.250

Review 6.  The Role of Reelin Signaling in Alzheimer's Disease.

Authors:  Nan-Nan Yu; Meng-Shan Tan; Jin-Tai Yu; An-Mu Xie; Lan Tan
Journal:  Mol Neurobiol       Date:  2015-10-21       Impact factor: 5.590

7.  Early effects of lipopolysaccharide-induced inflammation on foetal brain development in rat.

Authors:  Cristina A Ghiani; Natalia S Mattan; Hiroko Nobuta; Jemily S Malvar; Julie Boles; Michael G Ross; James A Waschek; Ellen M Carpenter; Robin S Fisher; Jean de Vellis
Journal:  ASN Neuro       Date:  2011-11-17       Impact factor: 4.146

8.  Sex-dimorphic effects of biogenesis of lysosome-related organelles complex-1 deficiency on mouse perinatal brain development.

Authors:  Frank Y Lee; Jennifer Larimore; Victor Faundez; Esteban C Dell'Angelica; Cristina A Ghiani
Journal:  J Neurosci Res       Date:  2020-05-20       Impact factor: 4.433

9.  Reelin immunoreactivity in neuritic varicosities in the human hippocampal formation of non-demented subjects and Alzheimer's disease patients.

Authors:  Tina Notter; Irene Knuesel
Journal:  Acta Neuropathol Commun       Date:  2013-06-26       Impact factor: 7.801

10.  Increased Blood-Reelin-Levels in First Episode Schizophrenia.

Authors:  Tobias Hornig; Carola Haas; Lukas Sturm; Bernd Fiebich; Ludger Tebartz van Elst
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.